[Hyperhomocysteinemia, coagulation disorders, inflammations: new risk factors for stroke].
Kammerer
Susanne
S
D000328:Adult; D001778:Blood Coagulation Disorders / Q000150:complications* / Q000235:genetics; D002097:C-Reactive Protein / Q000032:analysis*; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D011322:Primary Prevention; D011379:Prognosis; D011736:Pyridoxine / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D012851:Sinus Thrombosis, Intracranial / Q000209:etiology; D020521:Stroke / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000627:therapeutic use
D002097:C-Reactive Protein; D005492:Folic Acid; D011736:Pyridoxine; D014805:Vitamin B 12